RxDoctor Payments Data

Yvonne Mouchette

Nurse Practitioner · Las Cruces, NMNPI 1649427451

Payments from drug & device makers

$227in general payments, 2019–2025

Across 15 payments — averaging $15.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$55
  • Novo Nordisk$46
  • Lilly USA, LLC$35
  • Indivior Inc.$28
  • Novartis$22
  • Acella Pharmaceuticals, LLC$16
  • plus $26 from 2 others

What the payments were for

  • Food & beverage$227100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$227 in reported general payments places this provider in the 70th percentile of 624 nurse practitioner providers in New Mexico.

See all nurse practitioner providers in New Mexico

Medicare billing

Part B allowed, 2024
$135,131
Medicare patients
139
Services billed
4,091

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide47$67,647
MounjaroTirzepatide19$34,991
FarxigaDapagliflozin Propanediol32$26,960
LinzessLinaclotide39$24,934
EliquisApixaban14$23,139
JanuviaSitagliptin Phosphate14$22,360
RybelsusSemaglutide11$18,669
Levothyroxine Sodium257$4,528
ProgesteroneProgesterone, Micronized62$3,466
Famotidine21$3,246
Estradiol16$2,632
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$2,443
Omeprazole63$2,345
NitrofurantoinNitrofurantoin Macrocrystal56$2,330
Armour ThyroidThyroid,pork22$2,307

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$46$86,31658 claims
Lilly USA, LLCMounjaro$35$34,99119 claims
AstraZenecaFarxiga$55$26,96032 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 624 nurse practitioner providers in New Mexico.

Other nurse practitioner in Las Cruces

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →